Answers are grounded in this paper and cite their sources.
High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 µg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations >2 µg/mL.
No takes yet. Share an insight, caveat, or question.
Munita et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: